Diabetic Medicine: A Journal of the British Diabetic Association 2002: Vol 19 Index

15 Pages·2002·2.5 MB·English

\»A'l Indexes 1041
Batty, G.D., Shipley, M.J., Marmot, M. & Davey Smith, G. Bougneres, P.F. see Coutant, R.
Physical activity and cause-specific mortality in men with Type 2 Boulton, A.J.M. see Abbott, C.A.
diabetes/impaired glucose tolerance: evidence from the Whitehall Boulton, A.J.M. see Armstrong, D.G.
study, 580 Boulton, A.J..M. see Chaturvedi, N.
Bayly, G.R. see Lambert, A.P. Boulton, A.J.M. see Jude, E.B.
Beck-Nielsen, H. see Bentzen, J. Boulton, A.J..M. see Oyibo, S.O.
Bednarz, A.L. see Poulton, J. Boulton, A.J.M. see Paisley, A.N.
Behrend, C. see Boehm, B.O. Bowen, K. see Kenardy, J.
Bellary, S. Exercise consultation in diabetes, 886 Boyce, J.F. see Sinthanayothin, C.
Beltramello, G.P. see Bruttomesso, D. Boyle, D.I.R. see Donnan, P.T.
Bennetts, B.H. see Kao, Y. Brailsford, S. see Davies, M.
Bentzen, J., Poulsen, P., Vaag, A., Beck-Nielsen, H. &C Fenger, M. Braspenning, J.C.C. see Frijling, B.D.
The influence of the polymorphism in apolipoprotein B codon Bril, V. &C Perkins, B.A. Comparison of vibration perception
2488 on insulin and lipid levels in a Danish twin population, 12 thresholds obtained with the Neurothesiometer and the CASE IV
Berger, D., Barroso, I., Soos, M., Yeo, G., Schafer, A.J., O’Rahilly, and relationship to nerve conduction studies, 661
S. & Whitehead, J.P. Genetic variants of insulin receptor Broadbent, D.M. see Younis, N.
substrate-1 (IRS-1) in syndromes of severe insulin resistance. Broers, S., le Cessie, S., van Vliet, K.P., Spinhoven, Ph., van der
Functional analysis of Ala513Pro and Glyll58Glu IRS-1, 804 Ven, N.C.W. & Radder, J.K. Blood Glucose Awareness Training
Berger, M. see Linkeschova, R. in Dutch Type 1 diabetes patients. Short-term evaluation of
Berger, M. see Neuvians, T.P. individual and group training, 157
Berger, M. see Trautner, C. Broomhall, J. see Donnan, P.T.
Berliner, S. see Elishkevitz, K. Brown, R.S. see Kipps, S.
Besser, R. ‘Paint me a Hypo’, 343 Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E.,
Betteridge, D.J. see Colhoun, H.M. Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M.,
Bhattacharyya, A., Christodoulides, C., Kaushal, K., New, J.P. & Moretti, M., Confortin, L., Beltramello, G.P., Pais, M.,
Young, R.J. In-patient management of diabetes mellitus and Baritussio, A., Casiglia, E. & Tiengo, A. Continuous
patient satisfaction, 412 subcutaneous insulin infusion (CSII) in the Veneto region:
Bingley, P.J. see Douek, I.F. efficacy, acceptability and quality of life, 628
Blackledge, H. see Hayward, L.M. Bruzzo, F. see Taverna, .M.J.
Blakytny, R. see Jude, E.B. Buch, H.N., Baskar, V., Barton, D.M., Kamalakannan, D.,
Bo, S., Cavallo-Perin, P., Gentile, L., Repetti, E. & Pagano, G. Type Akarca, C. & Singh, B.M. Combination of insulin and
2 diabetes with onset in the elderly is not a benign disease, 792 thiazolidinedione therapy in massively obese patients with
Bodansky, H.J. see Feltbower, R.G. Type 2 diabetes, 572
Boehm, B.O., Home, P.D., Behrend, C., Kamp, N.M. & Lindholm, Bulmer, J. see Jude, E.B.
A. Premixed insulin aspart 30 vs. premixed human insulin 30/70 Burden, A.C. see Hayward, L.M.
twice daily: a randomized trial in Type 1 and Type 2 diabetic Burden, M.L. see Hayward, L.M.
patients, 393 Butler, D. see Anderson, B.J.
Bogardus, C. see Lindsay, R.S. Buysschaert, M. see Hermans, M.P.
Bokemark, L., Wikstrand, J., Wedel, H. & Fagerberg, B. Insulin, Byrne, K. see McFarlane, S.I.
insulin propeptides and intima-media thickness in the carotid
artery in 58-year-old clinically healthy men. The Atherosclerosis Calcaterra, F. see Bonora, E.
and Insulin Resistance study (AIR), 144 Calo, L. see lori, E.
Bolli, G.B. see Herz, M. Canning, C. see Davies, M.
Bonadonna, R.C. see Bonora, E. Cantero-Aguilar, L. see Coutant, R.
Bonora, E., Targher, G., Alberiche, M., Formentini, G., Carel, J.C. see Coutant, R.
Calcaterra, F., Lombardi, S., Marini, F., Poli, M., Zenari, L., Carr, M.E., Krishnaswami, A. & Martin, E.J. Platelet contractile
Raffaelli, A., Perbellini, S., Zenere, M.B., Saggiani, F., force (PCF) and clot elastic modulus (CEM) are elevated in
Bonadonna, R.C. & Muggeo, M. Predictors of insulin sensitivity diabetic patients with chest pain, 862
in Type 2 diabetes mellitus, 535 Carrington, A.L. see Abbott, C.A.
Borch-Johnsen, K. IGT and IFG. Time for revision? 707 Casiglia, E. see Bruttomesso, D.
Borgo, E. see Trento, M. Casson, I.F. see Platt, M.J.
Borretta, G. see Procopio, M. Cassone-Faldetta, M. see Fava, D.
Bosman, D.R., Osborne, C.A., Marsden, J.T., Macdougall, l.C., Cavallo, F. see Trento, M.
Gardner, W.N. & Watkins, P.J. Erythropoietin response to Cavallo-Perin, P. see Bo, S.
hypoxia in patients with diabetic autonomic neuropathy and Cavan, D.A. see Kerr, D.
non-diabetic chronic renal failure, 65 Ceolotto, G. see lori, E.
Bosnyak, Zs. see Tabak. A.Gy. Cesario, F. see Procopio, M.
Botha, J.L. see Hayward, L.M. le Cessie, S. see Broers, S.
Bott, S. see Heise, T. Chan, A. see Kao, Y.
Bott, U. see Linkeschova, R. ■ Chan, A.K.F. see Duffin, A.C.
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
1042 Indexes
ChanJ.C.N. see Ko, G.T.C. Davis, W.A. see Balme, M.
Chan, J.C.N. see So, W.Y. Day, A.P. see Lambert, A.P.
Chang, Y.F. see Hayward, L.M. Dayan, C.M. see Lambert, A.P.
Chase, H.P., Saib, S.Z., MacKenzie, T., Hansen, M.M. & Garg, S.K. De Luca, O. see Fava, D.
Post-prandial glucose excursions following four methods of De Mattia, G. see Fava, D.
bolus insulin administration in subjects with Type 1 diabetes, De Pergola, G. see Pannacciulli, N.
317 Deepa, R. see Mohan, V.
Chaturvedi, N. Differing aspects of insulin resistance in diabetes Deepa, R. see Rema, M.
complications: the shape of things to come. RD Lawrence lecture Deepak, D., Ingham, D., Reynolds, R.M. &C Walker, J.D. A case of
2000, 973 euglycaemic diabetic ketoacidosis in pregnancy—a reply, 699
Chaturvedi, N. see Kempler, P. Deiss, D. see Kordonouri, O.
Chaturvedi, N., Abbott, C.A., Whalley, A., Widdows, P., Dekker, J.M. see Adriaanse, M.C.
Leggetter, S.Y. & Boulton, A.J.M. Risk of diabetes-related Dela, F. see Koning, E.J.P.
amputation in South Asians vs. Europeans in the UK, 99 Delgado, J.A. see Abad, F.
Chevalier, A. see Taverna, .M.J. Demaine, A.G. see Zhao, H.X.
Chiarelli, F. see S. Mohn, A. Derfler, K. see Maca, T.H.
Cho, Y.M. see Kim, j.H. DeVries, J.H., Eskes, S.A., Snoek, E.J., Pouwer, E.,
Choi, D.S. see Choi, K.M. van Ballegooie, E., Spijker, A.J., Kostense, P.J., Seubert, M. &
Choi, K.M., Lee, J., Kim, D.R., Kim, S.K., Shin, D.H., Kim, N.H., Heine, R.J. Continuous intraperitoneal insulin infusion
Park, LB., Choi, D.S. & Baik, S.H. Comparisonof ADAand WHO in patients with ‘brittle’ diabetes: favourable effects on glycaemic
criteria for the diagnosis of diabetes in elderly Koreans, 853 control and hospital stay, 496
Chow, C.C. see So, W.Y. Di Luzio, R. see S. Mohn, A.
Chowdury, T. & Lasker, S.S. Predicting CHD risk in patients with Di Michele, see S. Mohn, A.
diabetes, 83 Di'az-Gomez, N.M. see Abad, E.
Christidis, D. see Liberopoulos, E. Didjurgeit, U., Kruse, J., Schmitz, N., Stiickenschneider, P. &
Christodoulides, C. see Bhattacharyya, A. Sawicki, P.T. A time-limited, problem-orientated
Chuang, L.-M., Tsai, S.T., Huang, B.Y., Tai, T.Y. The status of psychotherapeutic intervention in Type 1 diabetic patients with
diabetes control in Asia—a cross-sectional survey of 24 317 complications: a randomized controlled trial, 814
patients with diabetes mellitus in 1998, 978 Dole, G. see Sampson, M.J.
Chung, S.S.M. see Liu, Y.F. Donaghue, K.C. see Duffin, A.C.
Close, C.F. see Lambert, A.P. Donaghue, K.C. see Kao, Y.
Clover, A. see Litwin, A.S. Donnan, P.T. see Evans, J.M.M.
Cockram, C.S. see So, W.Y. Donnan, P.T., Boyle, D.I.R., Broomhall, J., Hunter, K.,
Coker, R. see Shapo, L. MacDonald, T.M., Newton, R.W. 8c Morris, A.D. Prognosis
Colhoun, H.M., Thomason, M.J., Mackness, M.L, Maton, S.M., following first acute myocardial infarction in Type 2 diabetes: a
Betteridge, D.J., Durrington, P.N., Hitman, G.A., Neil, H.A.W. comparative population study, 448
& Fuller, J.H. Design of the Collaborative AtoRvastatin Donnan, P.T., MacDonald, T.M. 8c Morris, A.D. Adherence to
Diabetes Study (CARDS) in patients with Type 2 diabetes, 201 prescribed oral hypoglycaemic medication in a population of
Confortin, L. see Bruttomesso, D. patients with Type 2 diabetes: a retrospective cohort study, 279
Connell, A. see Anderson, B.J. Donnan, P.T., Steinke, D.T., Newton, R.W. 8c Morris, A.D.
Cook, H.L. see Sinthanayothin, C. Changes in treatment after the start of oral hypoglycaemic
Coutant, R., Palmer, P., Carel, j.C., Cantero-Aguilar, L., Lebon, P., therapy in Type 2 diabetes: a population-based study, 606
Bougneres, P.F. Detection of enterovirus RNA sequences in Donovan, J. see Valabhji, J.
serum samples from autoantibody-positive subjects at risk for Dorchy, H. Improving outcomes for young people with diabetes,
diabetes, 968 702
Crazzolara, D. see Bruttomesso, D. Dorow, A. see Kordonouri, O.
Cundy, T. see Farrell, T. Douek, I.E., Leech, N.J., Bingley, P.J. 8c Gale, E.A.M. Eczema and
Cundy, T. see Petrie, K.J. Type 1 diabetes, 174
Cundy, T., Slee, F., Gamble, G. & Neale, L. Hypertensive disorders Dressier, A. see Heise, T.
of pregnancy in women with Type 1 and Type 2 diabetes, 482 Duffin, A.C., Lam, A., Kidd, R., Chan, A.K.E., Donaghue, K.C.
Ultrasonography of plantar soft tissues thickness in young people
D’Agostino Jr, R. see Festa, A. with diabetes, 1009
Danne, T. see Kordonouri, O. Duke, T. see Hayward, L.M.
Daures, J.-P. see Richard, J.-L. Dunger, D.B. see Kipps, S.
Davey Smith, G. see Batty, G.D. Durrington, P.N. see Colhoun, H.M.
Davies, M., Roderick, P., Canning, C. & Brailsford, S. The Durston, J. see Gill, G.
evaluation of screening policies for diabetic retinopathy using Dzien, A. see Lechleitner, M.
simulation, 762 Dzien-Bischinger, C. see Lechleitner, M.
Davis, G. see Ezenwaka, C.E.
Davis, T.M.E. see Balme, M. Eaton, S. see Kempler, P.
,
© 2002 Diabetes UK. Diabetic Medicine, 19 1040-1055
Indexes 1043
Edge, J.A. see Kipps, S. Fitzpatrick, R. see Garratt, A.M.
Eguchi, K. see Takino, H. Formentini, G. see Bonora, E.
Ehlin, A.G.C. see Montgomery, S.M. Fowelin, J.H.R. see Johansson, K.E.A.
Ehringer, H. see Maca, T.H. Fox, C.T. see Kipps, S.
van Eijk, J.T.M. see van de Poll-Franse, L.V. Fran(;ois, L. see Martin, D.
Eisma, W.H. see Meijer, J.W.G. Freeman, M.S., Mansfield, M.W., Barrett, J.H., Grant, P.J.
Ekbom, A. see Montgomery, S.M. Heritability of features of the insulin resistance syndrome in a
El-Gammal, A. see Shaltout, A. A. community-based study of healthy families, 994
Eliasson, M., Lindahl, B., Lundberg, V. &c Stegmayr, B. No increase Frier, B.M. see Herz, M.
in the prevalence of known diabetes between 1986 and 1999 in Frijling, B.D., Lobo, C.M., Hulscher, M.E.J.L., Akkermans, R.P.,
subjects 25-64 years of age in northern Sweden, 874 Braspenning, J.C.C., Prins, A., van der Wouden, J.C. &
Elisaf, M. see Liberopoulos, E. Grol, R.P.T.M. Multifaceted support to improve clinical decision
Elishkevitz, K., Fusman, R., Koffler, M., Shapira, I., Zeltser, D., making in diabetes care: a randomized controlled trial in general
Avitzour, D., Arber, N., Berliner, S. & Rotstein, R. Rheological practice, 836
determinants of red blood cell aggregation in diabetic patients in Fujiwara, Y. see Aso, Y.
relation to their metabolic control, 152 Fukushima, M. see Nakai, Y.
Elkeles, R.S. see Valabhji, J. Fuller, J.H. see Colhoun, H.M.
Ellard, S. see Owen, K.R. Fuller, J.H. see Kempler, P.
Ellingford, A. see Leese, G.P. Fusman, R. see Elishkevitz, K.
Ellis, J.D. see Leese, G.P.
Engstrom, G. & Janzon, L. Risk of developing diabetes in inversely Gale, E.A.M. see Douek, l.E.
related to lung function: a population-based cohort study, 167 Gamble, G. see Cundy, T.
Engstrom, G. see Hedblad, B. Gandjour, A., Kleinschmit, F. & Lauterbach, K.W. European
Eskes, S.A. see DeVries, J.H. comparison of costs and quality in the prevention of secondary
Eskildsen, P.C. see Ihlemann, N. complications in Type 2 diabetes mellitus (2000-2001), 594
Evans, J.M.M., Donnan, P.T. & Morris, A.D. Adherence to oral Gardner, W.N. see Bosman, D.R.
hypoglycaemic agents prior to insulin therapy in Type 2 diabetes, Garg, A. see Haque, W.A.
685 Garg, S.K. see Chase, H.P.
Every, L.C. see Abbott, C.A. Garratt, A.M., Schmidt, L. & Fitzpatrick, R. Patient-assessed
Ezenwaka, C.E., Offiah, N.V., Kalloo, R. &c Davis, G. The importance health outcome measures for diabetes: a structured review, 1
of diabetes health education in developing countries, 432 Gautier, J.F. see Sobngwi, E.
Ge, Y., MacDonald, D., Halt, H., Lipsky, B., Zasloff, M. &
Eagerberg, B. see Bokemark, L. Holroyd, K. Microbiological profile of infected diabetic
Earrell, T., Neale, L. &: Gundy, T. Congenital anomalies in the foot ulcers, 1032
offspring of women with Type 1, Type 2 and gestational diabetes, Gennaro, R. see Bruttomesso, D.
322 Gentile, L. see Bo, S.
Fava, D., Cassone-Faldetta, M., Laurenti, O., De Luca, O., Ghiselli, A. Gerel, B. see Suvd, J.
& De Mania, G. Gliclazide improves anti-oxidant status and Ghiselli, A. see Fava, D.
nitric oxide-mediated vasodilation in Type 2 diabetes, 752 Giani, G. see Trautner, C.
van der Feen, C., Neijens, F.S., Ranters, S.D.J.M., Mali, Gibbins, R. see Trento, M.
W.P.Th..M., Stolk, R.P. & Banga, J.D. Angiographic distribution Gill-Randall, R. see Alcolado, J.C.
of lower extremity atherosclerosis in patients with and without Gill, G., Durston, J., Johnson, R., MacLeod, K. & Watkins, P.
diabetes, 366 Insulin-treated diabetes and driving in the UK, 435
Feinle, C. see Horowitz, M Gill, G. Poor glycaemic control in female Type 1 adolescents—the
Feltbower, R.G., Bodansky, H.J., McKinney, P.A., Houghton, J., ‘fragile female diabetic’ revisited? 699
Stephenson, C.R. & Haigh, D. Trends in the incidence of Gill, G. The Diabetes Annual 13, 342
childhood diabetes in south Asians and other children in Gill, G.V. see Abbas, Z.G.
Bradford, UK, 162 Gill, G.V. see Rotchford, A.P.
Felton, A. see Munro, N. Giorgino, F. see Pannacciulli, N.
Fenger, M. see Bentzen, J. Giorgino, R. see Pannacciulli, N.
Ferguson, M.W.J. see Jude, E.B. Gissler, M. see Vaarasmaki, M.
Ferguson, S.C. see Herz, M. Goebel-Fabbri, A. see Anderson, B.J.
Ferrannini, E. & Balkan, B. Insulin: in search of a syndrome, 724 Gokal, R. see Oyibo, S.O.
Festa, A., D’Agostino Jr, R., Tracy, R.P. & Haffner, S.M. Gough, K. see Strachan, M.W.J.
C-reactive protein is more strongly related to post-glucose Grant, P.J. see Freeman, M.S.
load glucose than to fasting glucose in non-diabetic subjects; Grasset, E. see Martin, D.
the Insulin Resistance Atherosclerosis Study, 939 Green, B. see Kenardy, J.
Finnstrom, K. see Kullberg, C.E. Greene, S.A. see Howells, L.
Fisher, M. Diabetes and Cardiovascular Disease, 260 Greenwood, R.H. see Sampson, M.J.
Fisher, N.D.L. see Price, D.A. Gregory, R. see Swift, B.
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
•a\\
1044 Indexes •
Greneche, M.O. see Martin, D. Hennessy, A.-R., Reynolds, R.M. & Walker, J.D. Blood glucose
Griffin, N.K. see Kipps, S. measurement in acute medicine: inadequate detection and
Griffiths, J. see Abbott, C.A. management, 698
Grol, R.P.T.M. see Frijling, B.D. Hennessy, A.R. 8c Walker, J.D. Silent hypoglycaemia at the
Groothoff, J.W. see Meijer, J.W.G. diabetic clinic, 261
Griiters-Kieslich, A. see Kordonouri, O. Hermans, M.P., Van Leberghe, S. 8c Buysschaert, M. The
Gschwandtner, M.E. see Maca, T.H. [C282Y/wt] heterozygous HFE genotype is associated
Guarneri, G. see Bruttomesso, D. with lower blood pressure and HDL-cholesterol in Type 2
Gulam-Abbas, Z.G., Lutale, J.K., Morbach, S. & Archibald, L.K. diabetes, 796
Clinical outcome of diabetes patients hospitalized with foo't Hernandez, C., Lecube, A., Segura, R.M., Sararols, L. 8c Simo, R.
ulcers, Dar es Salaam, Tanzania, 575 Nitric oxide and vascular endothelial growth factor
Gustafsson, J. see Tylleskar, K. concentrations are increased but not related in vitreous fluid of
Gutniak, M.K. see Ahren, B. patients with proliferative diabetic retinopathy, 655
Guyot-Argenton, C. seeTaverna, M.J. Herold, M. see Lechleitner, M.
Herz, M., Arora, V., Sun, B., Ferguson, S.C., Bolli, G.B. 8c
Haastert, B. see Trautner, C. Frier, B.M. Basal-bolus insulin therapy in Type 1 diabetes:
Hadithi, M., Toorians, A. & Heine, R. The Houssay phenomenon, comparative study of pre-meal administration of a fixed mixture
another clue to Sheehan’s syndrome in a diabetic, 795 of insulin lispro (50%) and neutral protamine lispro (50%) with
Haffner, S.M. see Festa, A. human soluble insulin, 917
Haigh, D. see Feltbower, R.G. Heyburn, P.J. see Sampson, M.J.
Hait, H. see Ge, Y. Hilsted, J. see Rosenfalck, A.M.
Hamada, Y. see Takeuchi, N. Hiramatsu, K. see Sato, Y.
Hamilton, P. see Kerr, D. Hitman, G.A. see Colhoun, H.M.
Hampson, S.E. see Asimakopoulou, K.G. Ho, L.T. see Kuo, C.S.
Handley, G. see Wahid, S.T. Hodgkins, P.R. see Litwin, A.S.
Hann, A.W. see Abbott, C.A. Hodson, M.E. see Yung, B.
Hanna, E.W.E. &c Peters, J.P,. Screening for gestational diabetes; Hollenberg, N.K. see Price, D.A.
past, present and future, 351 Holroyd, K. see Ge, Y.
Hansen, M.M. see Chase, H.P. Holst, J.J. see Ahren, B.
Hanson, R.L. see Lindsay, R.S. Holt, T.A. A chaotic model for tight diabetes control, 274
Haque, W.A., Vuitch, E., Garg, A. Post-mortem findings in familial Home, P.D. see Boehm, B.O.
partial lipodystrophy, Dunnigan variety, 1022 Home, P.D. see Marshall, S.M.
Hara, T. see Takeuchi, N. Hooper, J. see Yung, B.
Harding, S.P. see Younis, N. Hoppichler, E. see Lechleitner, M.
Hardy, K.J. see Hulme, S.A. Hdrl, W.H. see Maca, T.H.
Hartikainen, A.-L. see Vaarasmaki, M. Horowitz, M., O’Donovan, D., Jones, K.L., Feinle, C., Rayner, C.K.
Harvey, I. see Sampson, M.J. 8c Samson, M. Gastric emptying in diabetes: clinical significance
Hasegawa, G. see Kamiuchi, K. and treatment, 177
Hasegawa, G. see Kitamura, A. Hotta, N. see Kondo, K.
Hashizume, K. see Sato, Y. Hotta, N. see Takeuchi, N.
Hattersley, A.T. see Owen, K.R. Houghton, J. see Feltbower, R.G.
Hawkins, P.N. see Swift, B. Howard, C.V. see Platt, M.J.
Hayward, L.M., Burden, M.L., Burden, A.C., Blackledge, H., Howells, L., Wilson, A.C., Skinner, T.C., Newton, R., Morris, A.D.
Raymond, N.T., Botha, J.L., Karwatowski, W.S.S., Duke, T. & 8c Greene, S.A. A randomized control trial of the effect of
Chang, Y.F. What is the prevalence of visual impairment in the negotiated telephone support on glycaemic control in young
general and diabetic populations: are there ethnic and gender people with Type 1 diabetes, 643
differences? 27 Howlett, H. see Marre, M.
Hedblad, B., Nilsson, P., Engstrom, G. &c Janzon, L. Insulin Hsiao, L.C. see Kuo, C.S.
resistance in non-diabetic subjects is associated with increased Huang, B.Y. see Chuang, L.-M.
incidence of myocardial infarction and death, 470 Huh, K.B. see Ahn, C.W.
Heine, R. see Hadithi, M. Hulme, S.A., Tin-U, A., Hardy, K.J. 8c Joyce, P.W. Evaluation of a
Heine, R.j. see Adriaanse, M.C. district-wide screening programme for diabetic retinopathy
Heine, R.J. see DeVries, J.H. utilizing trained optometrists using slit-lamp and Volk lenses,
Heine, R.J. see van de Poll-Franse, L.V. 741
Heinemann, L. see Heise, T. Hulscher, M.E.J.L. see Frijling, B.D.
Heise, T., Bott, S., Rave, K., Dressier, A., Rosskamp, R. &c Humphries, J. see Sampson, M.J.
Heinemann, L. No evidence for accumulation of insulin glargine Hunt, M.A. see Lambert, A.P.
(LANTUS®): a multiple injection study in patients with Type 1 Hunter, K. see Donnan, P.T.
diabetes, 490 Hussein, A. see Abbott, C.A.
Heller, S. Mistaken priorities in diabetes research, 263 Hwu, C.M. see Kuo, C.S.
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
\fA\
Indexes 1045
Ichikawa, K. see Sato, Y. Karwatowski, W.S.S. see Hayward, L.M.
Ihlemann, N., Stokholm, K.H. & Eskildsen, P.C. Impaired vascular Katakura, M. see Sato, Y.
reactivity is present despite normal levels of von Willebrand Kato, Y., Miura, Y., Inagaki, A., Itatsu, T. & Oiso, Y. Age of onset
factor in patients with uncomplicated Type 2 diabetes, 476 posssibly associated with the degree of heteroplasmy in two male
Inagaki, A. see Kato, Y. siblings with diabetes mellitus having an A to G transition at
Ingham, D. see Deepak, D. 3243 of mitochondrial DNA, 784
Inukai, G. see Matsumoto, K. Katzenschlager, R. see Maca, T.H.
Inukai, T. see Aso, Y. Kaushal, K. see Bhattacharyya, A.
lori, E., Calo, L., Valbusa, D., Ceolotto, G., Milani, M., Pengo, V., Kawakami, A. see Nagasaka, S.
de Kreutzenberg, S.V., Tiengo, A. & Avogaro, A. Diabetic ketosis Kawamura, T. see Takeuchi, N.
activates lymphomonocyte-inducible nitric oxide synthase, 777 Kawasaki, E. see Takino, H.
Ishibashi, S. see Nagasaka, S. Kemp, M. see Yung, B.
Ishii, M. see Kamiuchi, K. Kempler, P., Tesfaye, S., Chaturvedi, N., Stevens, L.K., Webb, D.J.,
Ishii, M. see Kitamura, A. Eaton, S., Kerenyi, Zs., Tamas, Gy., Ward, J.D. Sc Fuller, J.H.
Ishikawa, S. see Nagasaka, S. Autonomic neuropathy is associated with increased
Itatsu, T. see Kato, Y. cardiovascular risk factors: the EURODIAB IDDM
Complications Study, 900
Jackson, N. see Abbott, C.A. Kenardy, J., Mensch, M., Bowen, K., Green, B. 8c Walton, J.
Jackson, N.J. see Oyibo, S.O. Group therapy for binge eating in Type 2 diabetes: a randomized
James, E. see Oyibo, S.O. trial, 234
Jansen van Rosendaal, A. see Abbink, E.J. Kerenyi, Zs. see Kempler, P.
Janzon, L. see Engstrom, G. Kerenyi, Zs. see Tabak, A.Gy.
Janzon, L. see Hedblad, B. Kerr, D., Hamilton, P., Cavan, D.A. Preventing glycaemic
Jeon, H.J. see Kim, J.H. excursions in diabetic patients requiring percutaneous
Johansson, K.E.A., .Marklund, B.R.G. & Fowelin, J.H.R. endoscopic gastrostomy (PEG) feeding after a stroke, 1006
Evaluation of a new screening method for detecting peripheral Kerr, D., Nicholls, H. 8c Cavan, D.A. The lost tribes in diabetes,
arterial disease in a primary health care population of patients 703
with diabetes mellitus, 307 Kidd, R. see Duffin, A.C.
John, W.G. see Marshall, S.M. Kim, D.R. see Choi, K.M.
Johnson, K.E. see Abbott, C.A. Kim, H.S. see Ahn, C.W.
Johnson, R. see Gill, G. Kim, J.H., Park, K.S., Cho, Y.M., Kang, B.S., Kim, S.K., Jeon, H.J.,
Joner, G. see Stene, L.C. Kim, S.Y. 8c Lee, H.K. The prevalence of the mitochondrial
Jones, K.L. see Horowitz, M DNA 16189 variant in non-diabetic Korean adults and its
Jones, S.D. see Manning, P.J. association with higher fasting glucose and body mass index, 681
de Jong, S.A. see Manning, P.J. Kim, K.R. see Ahn, C.W.
Jousilahti, P. see Al-Lawati, J.A. Kim, N.H. see Choi, K.M.
Joyce, P.W. see Hulme, S.A. Kim, S.K. see Choi, K.M.
Jude, E.B. see Oyibo, S.O. Kim, S.K. see Kim, J.H.
Jude, E.B., Blakytny, R., Bulmer, J., Boulton, A.J.M. & Ferguson, King, H. see Ramachandran, A.
M.W.J. Transforming growth factor-beta 1,2, 3 and receptor King, H. see Suvd, J.
type I and II in diabetic foot ulcers, 440 Kipps, S., Bahu, T., Ong, K., Ackland, F.M., Brown, R.S.,
Fox, C.T., Griffin, N.K., Knight, A.H., Mann, N.P., Neil, H.A.W.,
Kalloo, R. see Ezenwaka, C.E. Simpson, H., Fledge, J.A. 8c Dunger, D.B. Current methods of
Kamalakannan, D. see Buch, H.N. transfer of young people with Type 1 diabetes to adult services,
Kamiuchi, K. see Kitamura, A. 649
Kamiuchi, K., Hasegawa, G., Obayashi, H., Kitamura, A., Ishii, M., Kishimoto, H. see Nakai, Y.
Yano, M., Kanatsuna, T., Yoshikawa, T. & Nakamura, N. Kitamura, A. see Kamiuchi, K.
Intercellular adhesion molecule-1 (ICAM-1) polymorphism is Kitamura, A., Hasegawa, G., Obayashi, H., Kamiuchi, K., Ishii, M.,
associated with diabetic retinopathy in Type 2 diabetes mellitus, Yano, M., Tanaka, T., Yamaguchi, M., Shigeta, H., Ogata, M.,
371 Nakamura, N., Yoshikawa, T. Interleukin-6 polymorphism
Kamp, N.M. see Boehm, B.O. (-634C/G) in the promotor region and the progression of
Kanai, A. see Takeuchi, N. diabetic nephropathy in Type 2 diabetes, 1000
Kanatsuna, T. see Kamiuchi, K. Kleinschmit, F. see Gandjour, A.
Kanazawa, Y. see Takino, H. Knight, A.H. see Kipps, S.
Kang, B.S. see Kim, J.H. Knight, J. see Kao, Y.
Kanters, S.D.J.M. see van der Feen, C. Knip, M. see Riihimaa, P.H.
Kao, Y., Donaghue, K.C., Chan, A., Bennetts, B.H., Knight, J. & Knowler, W.C. see Lindsay, R.S.
Silink, M. Paraoxonase gene cluster is a genetic marker for early Ko, B.C.B. see Liu, Y.F.
microvascular complications in Type 1 diabetes, 212 Ko, G.T.C. see So, W.Y.
Karvonen, M. see Sbaltout, A.A. Ko, G.T.C., Tam, W.H., Chan, J.C.N. 8c Rogers, M. Prevalence of
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
•:jii
1046 Indexes
gestational diabetes mellitus in Hong Kong based on the 1998 Lechleitner, M., Herold, M., Dzien-Bischinger, C., Hoppichler, E.,
WHO criteria, 80 Dzien, A. Tumour necrosis factor-alpha plasma levels in elderly
Koffler, M. see Elishkevitz, K. patients with Type 2 diabetes mellitus—observations over
Komatsu, M. see Sato, Y. 2 years, 949
Kondo, K., Matsubara, T., Nakamura,]. & Hotta, N. Lecube, A. see Hernandez, C.
Characteristic patterns of circadian variation in plasma Lee, H.C. see Ahn, C.W.
catecholamine levels, blood pressure and heart rate variability in Lee, H.K. see Kim, J.H.
Type 2 diabetic patients, 359 Lee, J. see Choi, K.M.
Koning, E.J.P., Visboll, T. & Dela, F. 19th Anglo-Danish-Dutch Lee, S.H. see Kuo, C.S.
Diabetes Group meeting, 259 Lee, Y.S. see Kuo, C.S.
Koopmanschap, M.A. see Redekop, W.K. Leech, N.J. see Douek, I.E.
Koppensteiner, R. see Maca, T.H. Leese, G.P., Ellis, j.D., Morris, A.D. & Fdlingford, A. Does direct
Kordonouri, O., Deiss, D., Danne, T., Dorow, A., Bassir, C. & ophthalmoscopy improve retinal screening for diabetic eye
Griiters-Kieslich, A. Predictivity of thyroid autoantibodies for disease by retinal photography? 867
the development of thyroid disorders in children and adolescents Leggetter, S.Y. see Chaturvedi, N.
with Type 1 diabetes, 518 Legrand, C. see Martin, D.
Koshima, I. see Usui, H. Lehert, P. see Marre, M.
Kostense, P.J. see DeVries, J.H. Leong, K.S. see Li Voon Chong, J.S.W.
de Kreutzenberg, S.V. see lori, E. Lepage, V. see Sobngwi, E.
Krishnaswami, A. see Carr, M.E. Levi, Z. see Rachmani, R.
Krolewski, A.S. see Weijnen, C.E. Levy, V. see Sobngwi, E.
Kroon, M. see Sarnblad, S. Li,J.K.Y. see So, W.Y.
Kruse, J. see Didjurgeit, U. Li Voon Chong, J.S.W., Leong, K.S., Wallymahmed, M., Sturgess, R.
Kullberg, C.E., Abrahamsson, M., Arnqvist, H.J., Finnstrom, K. & & MacFarlane, LA. Is coeliac disease more prevalent in young
Ludvigsson, J. Prevalence of retinopathy differs with age at onset adults with coexisting Type 1 diabetes mellitus and autoimmune
of diabetes in a population of patients with Type 1 diabetes, 924 thyroid disease compared with those with Type 1 diabetes
Kuo, C.S., Hwu, C.M., Kwok, C.F., Hsiao, L.C., Weih, M.J., mellitus alone? 334
Lee, S.H., Lee, Y.S. & Ho, L.T. Surrogate estimates of insulin Liberopoulos, E., Christidis, D. &C Elisaf, M. Marked
sensitivity in Chinese diabetic patients and their offspring, 735 hyperphosphataemia in a patient with diabetic ketoacidosis, 885
Kusaka, 1. see Nagasaka, S. Licha-Miintz, G. see Martin, D.
Kwok, C.F. see Kuo, C.S. Lim, S.K. see Ahn, C.W.
Kynde, K. see 0dum, L. Lindahl, B. see Eliasson, M.
Lindblad, U. see Ostgren, C.J.
Laaksonen, D.E., Lakka, T.A., Lakka, H.-M., Nyyssonen, K., Lindholm, A. see Boehm, B.O.
Rissanen, T., Niskanen, L.K. & Salonen, J.T. Serum fatty acid Lindow, S.W. see Rao, S.
composition predicts development of impaired fasting glycaemia Lindsay, R.S., Prochazka, M., Baier, L.J., Knowler, W.C.,
and diabetes in middle-aged men, 456 Bogardus, C. & Hanson, R.L. Currently identified genes
Laffel, L.M.B. see Anderson, B.J. affecting insulin resistance are not associated with birth weight in
Laffel, L.M.B. see Price, D.A. the Pima population, 882
Laing, 1. see Oyibo, S.O. Linkeschova, R., Raoul, .M., Bott, U., Berger, M. 8c Spraul, M. Less
Laing, 1. see Yates, A.P. severe hypoglycaemia, better metabolic control, and improved
Laji, K. see Alcolado, J.C. quality of life in Type 1 diabetes mellitus with continuous
Lakka, H.-M. see Laaksonen, D.E. subcutaneous insulin infusion (CSII) therapy; an observational
Lakka, T.A. see Laaksonen, D.E. study of 100 consecutive patients followed for a mean of 2 years,
Lai, S. see Sinthanayothin, C. 746
Lam, A. see Duffin, A.C. Links, T.P. see Meijer, J.W.G.
Lam, K.S.L. see Liu, Y.E. Lipsky, B. see Ge, Y.
Lam, K.S.L. see Tan, K.C.B. Litwin, A.S., Clover, A., Hodgkins, P.R. 8c Luff, A.J. Affluence is
I.ambert, A.P. &C Close, C.F. Charcot neuroarthropathy of the knee not related to delay in diagnosis of Type 2 diabetes as judged by
in Type 1 diabetes: treatment with total knee arthroplasty, 338 the development of diabetic retinopathy, 843
Lambert, A.P., Hunt, M.A., Day, A.P., Bayly, G.R. & Dayan, C..M. Liu, Y.E., Wat, N.M.S., Chung, S.S.M., Ko, B.C.B. 8c Lam, K.S.L.
Reproducibility of individualized coronary heart disease risk Diabetic nephropathy is associated with the 5'-end dinucleotide
calculations in patients with diabetes mellitus, 514 repeat polymorphism of the aldose reductase gene in Chinese
Lansang, M.C. see Price, D.A. subjects with Type 2 diabetes, 113
Lant, A.F see Yung, B. Lobo, C.M. see Erijling, B.D.
Lasker, S.S. see Chowdury, T. Lombardi, S. see Bonora, E.
Laurenti, O. see Fava, D. Lora, L. see Bruttomesso, D.
Lauterbach, K.W. see Gandjour, A. Ludvigsson, J. see Kullberg, C.E.
Leblanc, H. see Sobngwi, E. Luff, A.J. see Litwin, A.S.
Lebon, P. see Coutant, R. Lundberg, V. see Eliasson, M.
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
Indexes 1047
Lutale, J.K. see Gulam-Abbas, Z.G. Mbanya, J.C. see Sobngwi, E.
Lutterman, J.A. see Abbink, E.J. McAllister, 1. see Balme, M.
Lyaruu, I. see Neuhann, H.F. McColl, A.J. see Valabhji, J.
McFarlane, S.L, Byrne, K., Shin, J. 8c Williams, R. Intussusception
Maca, T.H., Ahmadi, R., Derfler, K., Ehringer, H., in an adult patient with severe hyperglycaemia—a case report,
Gschwandtner, M.E., Horl, W.H., Katzenschlager, R., 611
Miiller-Knesfjel, E., Koppensteiner, R., Schneider, B., Stiimpflen, A., McIntosh, C. see Munro, N.
Ugurluoglu, A. & Minar, E. Influence of lipoprotein(a) on McKee, M. see Shapo, L.
restenosis after femoropopliteal percutaneous transluminal McKendrick, O. see Platt, M.J.
angioplasty in Type 2 diabetic patients, 300 McKinney, P.A. see Feltbower, R.G.
Macaulay, V.A. see Poulton, J. McKnight, J.A. see Strachan, M.W.J.
MacDonald, D. see Ge, Y. Mclay, L. see Oyibo, S.O.
MacDonald, T.M. see Donnan, P.T. Meigs, J.B. see Weijnen, C.F.
Macdougall, I.C. see Bosman, D.R. Meijer, J.W.G., Smit, A.J., Sonderen, E.V., Groothoff, J.W.,
MacFarlane, LA. see Li Voon Chong, J.S.W. Eisma, W.H., Links, T.P. Symptom scoring systems to diagnose
Machattie, T. see Rotchford, A.P. distal polyneuropathy in diabetes: the Diabetic Neuropathy
MacKenzie, T. see Chase, H.P. Symptom score, 962
Mackness, M.I. see Colhoun, H.M. Melander, A. see Ostgren, C.J.
MacLeod, K. see Gill, G. Melchionda, N. see Serrano-Rios, M.
Madarasz, E. see Tabak, A.Gy. Mensah, E. see Sinthanayothin, C.
Madsbad, S. see Rosenfalck, A.M. Mensch, M. see Kenardy, J.
Magnus, P. see Stene, L.C. .Milani, M. see lori, E.
Magro, G. see Procopio, M. Millward, B.A. see Zhao, H.X.
Makino, H. see Usui, H. Minar, E. see Maca, T.H.
Mali, W.P.Th.M. see van der Feen, C. Miola, M. see Bruttomesso, D.
Manley, S.E. see Marshall, S.M. Miura, Y. see Kato, Y.
Mann, N.P. see Kipps, S. Miyake, S. see Matsumoto, K.
Manning, P.J., Sutherland, W.H.F., Allum, A.R., de Jong, S.A. & Mohammed, A.J. see Al-Lawati, J.A.
Jones, S.D. Effect of hormone replacement therapy on Mohan, V. see Rema, M.
inflammation-sensitive proteins in post-menopausal women Mohan, V. 8c Deepa, R. Author’s reply, 81
with Type 2 diabetes, 847 Mohn, A., Di Michele, S., Di Luzio, R., Tumini, S. 8c Chiarelli, F.
Mansell, P. Diabetes and driving, 617 The effects of subclinical hypothyroidism on metabolic control in
Mansfield, M.W. see Freeman, M.S. children and adolescents with Type 1 diabetes mellitus, 70
Marini, F. see Bonora, E. Molineri, N. see Procopio, M.
Marklund, B.R.G. see Johansson, K.E.A. •Mongillo, A. see Bruttomesso, D.
Marmot, M. see Batty, G.D. Montgomery, S..M., Ehlin, A.G.C., Ekbom, A., Wakefield, A.J.
Marre, M., Howlett, H., Lehert, P. &C Allavoine, T. Improved Pertussis infection in childhood and subsequent Type 1 diabetes
glycaemic control with metformin-glibenclamide combined mellitus, 986
tablet therapy (Glucovance®) in Type 2 diabetic patients Morbach, S. see Gulam-Abbas, Z.G.
inadequately controlled on metformin, 673 Moreno-Carretero, E. see Serrano-Rios, M.
Marsden, J.T. see Bosman, D.R. Moretti, M. see Bruttomesso, D.
Marshall, S.M., Home, P.D., Manley, S.E., Barth, J.H. & Morris, A.D. see Donnan, P.T.
John, W.G. Standardization of glycated haemoglobin, 429 Morris, A.D. see Evans, J.M.M.
Martin, D., Licha-Miintz, G., Grasset, E., Greneche, M.O., Nouet, D., Morris, A.D. see Howells, L.
Frani^ois, L., Legrand, C., Polak, M., Augendre-Ferrante, B., Morris, A.D. see Leese, G.P.
Tubiana-Rufi, N., Robert, J.J. Efficacy of Humalog® injections Morrish, N.J. see Asimakopoulou, K.G.
before an afternoon meal and their acceptance by children and Moussa, M.A.A. see Shaltout, A.A.
adolescents with Type 1 diabetes, 1026 Moyeed, R.A. see Zhao, H.X.
Martin, E.J. see Carr, M.E. Msuya, L. see Neuhann, H.F.
Masson, E.A. see Rao, S. Muggeo, M. see Bonora, E.
Maton, S.M. see Colhoun, H.M. Miiller-Knespel, E. see Maca, T.H.
Matsubara, T. see Kondo, K. Munro, N., Felton, A. 8c McIntosh, C. Is multidisciplinary learning
Matsuda, M. see Usui, H. effective among those caring for people with diabetes? 799
Matsumoto, K., Sera, Y., Ueki, Y., Inukai, G., Niiro, E. &
Miyake, S. Comparison of serum concentrations of soluble Nagasaka, S. see Nakai, Y.
adhesion molecules in diabetic microangiopathy and Nagasaka, S., Abe, T., Kawakami, A., Kusaka, L, Nakamura, T.,
macroangiopathy, 822 Ishikawa, S., Saito, T. 8c Ishibashi, S. Pioglitazone-induced hepatic
Matthews, D.R. see Wallace, T.M. injury in a patient previously receiving troglitazone with success, 347
Maurino, M. see Trento, M. Nagataki, S. see Takino, H.
Mauvais-Jarvis, F. see Sobngwi, E. Nagy, E. see Tabak, A.Gy.
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
1048 Indexes
Nakai, Y., Fukushima, M., Nakaishi, S., Kishimoto, H., Seino, Y., Oyibo, S.O., Prasad, Y.D.M., Jackson, N.J., Jude, E.B. & Boulton,
Nagasaka, S., Sakai, M. & Taniguchi, A. The threshold value for A.J.M. The relationship between blood glucose excursions and
insulin resistance on homeostasis model assessment of insulin painful diabetic peripheral neuropathy: a pilot study, 870
sensitivity, 346 Oyibo, S.O., Pritchard, G.M., Mclay, L., James, E., Laing, I.,
Nakaishi, S. see Nakai, Y. Gokal, R. & Boulton, A.J.M. Blood glucose overestimation in
Nakamura, J. see Kondo, K. diabetic patients on continuous ambulatory peritoneal dialysis
Nakamura, j. see Takeuchi, N. for end-stage renal disease, 693
Nakamura, N. see Kamiuchi, K.
Nakamura, N. see Kitamura, A. Pacher, N. see Taverna, M.J.
Nakamura, N. see Takeuchi, N. Padfield, P.L. see Strachan, M.W.J.
Nakamura, T. see Nagasaka, S. Pagano, G. see Bo, S.
Nam, J.H. see Ahn, C.W. Pais, M. see Bruttomesso, D.
Neale, L. see Cundy, T. Paisley, A.N., Abbott, C.A., van Schie, C.H.M. & Boulton, A.J.M.
Neale, L. see Farrell, T. A comparison of the Neuropen against standard quantitative
Neijens, F.S. see van der Feen, C. sensory-threshold measures for assessing peripheral nerve
.Neil, H.A.W. see Colhoun, H.M. function, 400
Neil, H.A.W. see Kipps, S. Palmer, P. see Coutant, R.
Neuhann, H.F., Warter-Neuhann, C., Lyaruu, 1. & Msuya, L. Pandit, R.J. & Taylor, R. Quality assurance in screening for
Diabetes care in Kilimanjaro region: clinical presentation and sight-threatening diabetic retinopathy, 285
problems of patients of the diabetes clinic at the regional referral Pang, R.W.C. see Tan, K.C.B.
hospital—an inventory before structured intervention, 509 Pannacciulli, N., De Pergola, G., Giorgino, F. & Giorgino, R. A
Neuvians, T.P. & Berger, M. Diabetes care in cats and dogs, 77 family history of Type 2 diabetes is associated with increased
New, J.P. see Bhattacharyya, A. plasma levels of C-reactive protein in non-smoking healthy adult
Newton, R. see Howells, L. women, 689
Newton, R.W. see Donnan, P.T. Parer-Richard, C. see Richard, J.-L.
Nicholls, A.J. The impact of atherosclerotic renovascular disease Park, l.B. see Choi, K.M.
on diabetic renal failure, 889 Park, K.S. see Kim, J.H.
Nicholls, H. see Kerr, D. Passera, P. see Trento, M.
Niessen, L.W. see Redekop, W.K. Pengo, V. see lori, E.
Niiro, E. see Matsumoto, K. Pennycook, S. see Platt, M.J.
Nilsson, P. see Hedblad, B. Perbellini, S. see Bonora, E.
Niskanen, L.K. see Laaksonen, D.E. Perez, R. see Abad, F.
Njolstad, P.R. see Sagen, J.V. Perkins, B.A. see Bril, V.
Noormohamed, F.H. see Yung, B. Perlemuter, L. & Yomtov, B. Feasibility and usefulness of dedicated
Nouet, D. see Martin, D. software and e-mail for self-monitoring blood glucose in treating
Nyyssonen, K. see Laaksonen, D.E. diabetes, 701
Peters, J.R. see Hrnna, F.W.F.
O’Donovan, D. see Horowitz, M Petrella, E. see Ahren, B.
O'Rahilly, S. see Berger, D. Petrie, K.J. & Cundy, T. Alternative medicine recommendations to
Obayashi, H. see Kamiuchi, K. patients with Type 2 diabetes visiting health product shops and
Obayashi, H. see Kitamura, A. pharmacies, 1035
Odum, L. & Kynde, K. Handling of blood samples for diagnosis of Pia, A. see Procopio, M.
diabetes mellitus, 345 Pianta, A. see Bruttomesso, D.
Offiah, N.V. see Ezenwaka, C.E. Pickkers, P. see Abbink, E.J.
Ogata, M. see Kitamura, A. Piovesan, A. see Procopio, M.
Ohfusa, H. see Sato, Y. Platt, M.J., Stanisstreet, M., Casson, I.F., Howard, C.V.,
Oishi, T. see Usui, H. Walkinshaw, S., Pennycook, S. &C McKendrick, O. St Vincent’s
Oiso, Y. see Kato, Y. Declaration 10 years on: outcomes of diabetic pregnancies, 216
Ong, K. see Kipps, S. van der Ploeg, H.M. see Adriaanse, M.C.
Osborne, C.A. see Bosman, D.R. Polak, M. see Martin, D.
Osei, S.Y. see Price, D.A. Poli, M. see Bonora, E.
Ostgren, C.J., Lindblad, U., Ranstam, J., Melander, A. & van de Poll-Eranse, L.V., Valk, G.D., Renders, C.M., Heine, R.J. &
Rastam, L. Glycaemic control, disease duration and P-cell function van Eijk, J.T.M. Longitudinal assessment of the developments of
in patients with Type 2 diabetes in a Swedish community. diabetic polyneuropathy and associated risk factors, 771
Skaraborg Hypertension and Diabetes Project, 125 Porta, M. see Trento, M.
Otgooloi, H. see Suvd, J. Poulsen, P. see Bentzen, J.
Owen, K.R., Shepherd, M., Stride, A., Ellard, S. & Hattersley, A.T. Poulton, J., Bednarz, A.L., Scott-Brown, M., Thompson, C.,
Heterogeneity in young adult onset diabetes: aetiology alters Macaulay, V.A., Simmons, D. The presence of a common
clinical characteristics, 758 mitochondrial DNA variant is associated with fasting insulin
Owens, D.R. see Trento, M. levels in Europeans in Auckland, 969
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
Indexes 1049
Pouwer, F. see DeVries, J.H. Rissanen, T. see Laaksonen, D.E.
Prasad, Y.D.M. see Oyibo, S.O. Ritvanen, A. see Vaarasmaki, M.
Price, D.A., Lansang, M.C., Osei, S.Y., Fisher, N.D.L., Robert, J.j. see Martin, D.
Laffel, L.M.B. & Hollenberg, N.K. Type 2 diabetes, obesity, Robinson, A.C.j. see Wahid, S.T.
and the renal response to blocking the renin system with Roderick, P. see Davies, M.
irbesartan, 858 Rodriguez, 1. see Abad, E.
Prins, A. see Frijling, B.D. Rogers, M. see Ko, G.T.C.
Pritchard, G.M. see Oyibo, S.O. Roglic, G. see Suvd, J.
Prochazka, M. see Lindsay, R.S. Ronningen, K.S. see Stene, L.C.
Procopio, M., Magro, G., Cesario, F., Piovesan, A., Pia, A., Rosenfalck, A.M., Almdal, T., Hilsted, J. 8c Madsbad, S. Body
Molineri, N., Borretta, G. The oral glucose tolerance test reveals composition in adults with Type 1 diabetes at onset and during
a high frequency of both impaired glucose tolerance and tbe first year of insulin therapy, 417
undiagnosed Type 2 diabetes mellitus in primary Rosskamp, R. see Heise, T.
hyperparathyroidism, 958 Rotchford, A.P., Rotchford, K.M., Machattie, T. 8c Gill, G.V.
Purevsuren, D. see Suvd, J. Assessing diabetic control—reliability of methods available in
resource poor settings, 195
Qabazard, M. see Shaltout, A.A. Rotchford, K.M. see Rotchford, A.P.
Rotstein, R. see Elishkevitz, K.
Rachmani, R., Levi, Z., Slavachevski, L, Avin, M. & Ravid, M. Russel, F.G.M. see Abbink, E.J.
Teaching patients to monitor their risk factors retards the Rutten,G.E.H.M. see Redekop, W.K.
progression of vascular complications in high-risk patients with Ryder, C.H. see Abbott, C.A.
Type 2 diabetes mellitus—a randomized prospective study, 385
Radder, J.K. see Broers, S. Saeed, B.O. see Wabid, S.T.
Raffaelli, A. see Bonora, E. Sagen, J.V., Njolstad, P.R. 8c Sovik, O. Reduced prevalence of
Rajeswaran, C. ADA/WHO diabetes diagnostic criteria late-diabetic complications in MODY3 with early diagnosis,
controversy—the Chennai chapter, 81 697
Ramachandran, A., Snehalatha, C., Vijay, V. & King, H. Impact of Saggiani, F. see Bonora, E.
poverty on the prevalence of diabetes and its complications in Saib, S.Z. see Chase, H.P.
urban southern India, 130 Saito, T. see Nagasaka, S.
Ranstam, J. see Ostgren, C.J. Sakai, M. see Nakai, Y.
Rao, S., Lindow, S.W. & Masson, E.A. Survey of pre-conception Sakamoto, N. see Takeuchi, N.
counselling, 615 Salonen, j.T. see Laaksonen, D.E.
Raoul, M. see Linkeschova, R. Sampson, M.J., Shepstone, L., Greenwood, R.H., Harvey, L,
Rastam, L. see Ostgren, C.J. Humphries, J., Heyburn, P.J., Temple, R.C. 8c Dole, G. An
Rave, K. see Heise, T. integrated mobile foot and retinal screening programme for
Ravid, M. see Rachmani, R. people with Type 2 diabetes managed in primary care, 74
Raymond, N.T. see Flayward, L.M. Samson, M. see Horowitz, M
Rayner, C.K. see Horowitz, M Sano, T. see Takeuchi, N.
Reach, G. see Taverna, M.J. Sararols, L. see Hernandez, C.
Redekop, W.K., Koopmanschap, M.A., Rutten, G.E.H.M., Saravanan, G. see Rema, M.
Wolffenbuttel, B.H.R., Stolk, R.P. & Niessen, L.W. Resource Sarnblad, S., Kroon, M. 8c Aman, J. The short insulin tolerance test
consumption and costs in Dutch patients with Type 2 diabetes lacks validity in adolescents with Type 1 diabetes, 51
mellitus. Results from 29 general practices, 246 Sato, Y., Komatsu, M., Katakura, M., Ohfusa, H., Yamada, S.,
Rema, M., Saravanan, G., Deepa, R. & Moban, V. Familial clustering Yamauchi, K., Hiramatsu, K., Ichikawa, K., Aizawa, T. 8c
of diabetic retinopathy in South Indian Type 2 diabetic patients, Hashizume, K. Diminution of early insulin response to glucose in
910 subjects with normal but minimally elevated fasting plasma
Renders, C.M. see van de Poll-Franse, L.V. glucose. Evidence for early P-cell dysfunction, 566
Repetti, E. see Bo, S. Sato, Y., Obfusa, H., Katakura, M., Komatsu, M., Yamada, S.,
Reynolds, R.M. see Deepak, D. Yamauchi, K., Ichikawa, K., Aizawa, T. 8c Hashizume, K. A
Reynolds, R..M. see Hennessy, A.-R. problem with the diagnosis of diabetes mellitus based on fasting
Rich, S.S. see Weijnen, C.F. plasma glucose, 82
Richards, C. see Swift, B. Sawicki, P.T. see Didjurgeit, U.
Richard, J.-L., Sultan, A., Daures, J.-P., Vannereau, D. & Parer- Scaldaferri, E. see Bruttomesso, D.
Richard, C. Diagnosis of diabetes mellitus and intermediate Schachter, M. see Valabhji, J.
glucose abnormalities in obese patients based on ADA (1997) Schafer, A.J. see Berger, D.
and WHO (1985) criteria, 292 van Schie, C.H.M. see Paisley, A.N.
Richmond, W., see Valabhji, J. Schmidt, L. see Garratt, A.M.
Riihimaa, P.H., Suominen, K., Knip, M., Tapanainen, P. 8c Schmitz, N. see Didjurgeit, U.
Tolonen, U. Cardiovascular autonomic reactivity is decreased in Schneider, B. see Maca, T.H.
adolescents with Type 1 diabetes, 932 Scott, A. Lipids and Vascular Disease Current Issues, 704
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055
•:jii
1050 Indexes
Scott-Brown, M. see Poulton, J. Spinhoven, Ph. see Broers, S.
Segura, R.M. see Hernandez, C. Spraul, M. see Linkeschova, R.
Seino, Y. see Nakai, Y. Stanisstreet, M. see Platt, M.J.
Selam, J.-L. see Taverna, M.J. Stegmayr, B. see Eliasson, M.
Sera, Y. see Matsumoto, K. Steinke, D.T. see Donnan, P.T.
Sera, Y. see Takino, H. Stene, L.C., Ronningen, K.S., Magnus, P. 8c Joner, G. Does HLA
Serrano-Rios, M., Melchionda, N. & Moreno-Carretero, E. Role genotype influence the relative risk of Type 1 diabetes conferred
of sibutramine in the treatment of obese Type 2 diabetic patients by dietary factors? 429
receiving sulphonylurea therapy, 119 Stenhouse, E.A. see Zhao, H.X.
Seubert, M. see DeVries, J.H. Stephenson, C.R. see Feltbower, R.G.
Shaltout, A.A., Moussa, M.A.A., Qabazard, M., Abdella, N., Stevens, L.K. see Kempler, P.
Karvonen, M., Al-Khawari, M., Al-Arouj, M., Al-Nakhi, A., Stokholm, K.H. see Ihlemann, N.
Tuomilehto, J. & El-Gammal, A. Further evidence for the Stolk, R.P. see Redekop, W.K.
rising incidence of childhood Type 1 diabetes in Kuwait, Stolk, R.P. see van der Feen, C.
522 Strachan, M.W.J., Gough, K., McKnight, J.A. 8c Padfield, P.L.
Shapira, I. see Elishkevitz, K. Ambulatory blood pressure monitoring: is it necessary for the
Shapo, L., Coker, R. 8c McKee, M. Tracking diabetes in Albania: a routine assessment of hypertension in people with diabetes, 787
natural experiment on the impact of modernization on health, Stride, A. see Owen, K.R.
87 Stiickenschneider, P. see Didjurgeit, U.
Shaw, J. see Unwin, N. Stiimpflen, A. see Maca, T.H.
Shepherd, M. see Owen, K.R. Sturgess, R. see Chong, J.S.W.
Shepstone, L. see Sampson, M.J. Sugimoto, T. see Usui, H.
Shigeta, H. see Kitamura, A. Sultan, A. see Richard, J.-L.
Shikata, K. see Usui, H. Sultan, J. see Wahid, S.T.
Shin, D.H. see Choi, K.M. Sun, B. see Herz, M.
Shin, J. see McFarlane, S.I. Suominen, K. see Riihimaa, P.H.
Shipley, M.J. see Batty, G.D. Sutherland, W.H.F. see Manning, P.J.
Silink, M. see Kao, Y. Suvd, J., Gerel, B., Otgooloi, H., Purevsuren, D., Zolzaya, H.,
Simmons, D. see Poulton, J. Roglic, G. 8c King, H. Glucose intolerance and associated factors
Simo, R. see Hernandez, C. in Mongolia: results of a national survey, 502
Simpson, H. see Kipps, S. Svartberg, J. see Ahren, B.
Singh, B.M. see Buch, H.N. Swift, B., Hawkins, P.N., Richards, C. 8c Gregory, R. Examination
Sinthanayothin, C., Boyce, J.F., Williamson, T.H., Cook, H.L., of insulin injection sites: an unexpected finding of localized
Mensah, E., Lai, S. 8c Usher, D. Automated detection of diabetic amyloidosis, 881
retinopathy on digital fungus images, 105
Skinnet, T.C. see Howells, L. Tabak, A.Gy., Kerenyi, Zs., Nagy, E., Bosnyak, Zs., Madarasz, E.
Skinner, T.C. see Snoek, F.J. 8c Tamas, Gy. Height and gestational diabetes mellitus, 344
Slama, G. see Taverna, M.J. Tack, C.J. see Abbink, E.J.
Slavachevski, I. see Rachmani, R. Tai, T.Y. see Chuang, L.-M.
Slee, F. see Cundy, T. Takemura, Y. see Aso, Y.
Smit, A.J. see Meijer, J.W'.G. Takeuchi, N., Kawamura, T., Kanai, A., Nakamura, N., Uno, T.,
Smits, P. see Abbink, E.J. Hara, T., Sano, T., Sakamoto, N., Hamada, Y., Nakamura, J. 8c
Snehalatha, C. see Ramachandran, A. Hotta, N. The effect of cigatette smoking on soluble adhesion
Snoek, F.J. see Adriaanse, M.C. molecules in middle-aged patients with Type 2 diabetes mellitus,
Snoek, F.J. see DeVries, J.H. 57
Snoek, F.J. 8c Skinner, T.C. Psychological counselling in Takino, H., Yamasaki, H., Abiru, N., Sera, Y., Abe, T.,
problematic diabetes: does it help? 265 Kawasaki, E., Yamagucbi, Y., Eguchi, K., Kanazawa, Y. 8c
So, W.Y., Chan, J.C.N., Yeung, V.T.F., Chow, C.C., Ko, G.T.C., Nagataki, S. Antibodies to GAD in Japanese patients classified as
Li, J.K.Y., Cockram, C.S. Sulphonylutea-induced Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive
hypoglycaemia in institutionalized elderly in Hong Kong, 966 marker for early insulin treatment—report of west Japan
Sobngwi, E., Vexiau, P., Levy, V., Lepage, V., Mauvais-Jarvis, F., (Kyushu, Yamaguchi, Osaka) study fot GAD Ab(+) diabetes,
Leblanc, H., Mbanya, J.C. 8c Gautier, J.F. Metabolic and 730
immunogenetic prediction of long-term insulin remission in Tam, S.C.F. see Tan, K.C.B.
African patients with atypical diabetes, 832 Tam, W.H. see Ko, G.T.C.
Sola, A. see Taverna, M.J. Tamas, Gy. see Kempler, P.
Sonderen, E.V. see Meijer, J.W.G. Tamas, Gy. see Tabak, A.Gy.
Song, Y.D. see Ahn, C.W. Tan, K.C.B., Tso, A.W.K., Tam, S.C.F., Pang, R. W.C., Lam, K.S.L.
Soos, M. see Berger, D. Acute effect of orlistat on post-prandial lipaemia and free
Sevik, O. see Sagen, J.V. fatty acids in overweight patients with Type 2 diabetes mellitus,
Spijker, A.J. see DeVries, J.H. 944
© 2002 Diabetes UK. Diabetic Medicine, 19, 1040-1055